Unlike HepG2, this cell line was not derived from cancer cells, but rather from skeletal muscle of a 19 year-old healthy donor and a cell line developed by retroviral knock-in of the TERT and CDK4 genes (Rokach et al., 2013). This evidence concerns the gene TERT and cancer.